Craig Fox is currently an Operating Partner (Lifesciences) at Oxford Science Enterprises and serves as a Board Director for multiple organizations, including Endlyz UK Limited, Kesmalea Therapeutics, and Human Centric Drug Discovery. Previously, they held positions such as Chief Scientific Officer and Head of Biology at C4X Discovery Ltd and directed respiratory research at both Argenta Discovery and Pulmagen Therapeutics Limited. Craig earned a Bachelor of Science in Biochemistry from the University of Surrey and a PhD in Medicine from the University of Birmingham.
This person is not in the org chart
This person is not in any teams
This person is not in any offices